CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • March 7th, 2017 • Loxo Oncology, Inc. • Pharmaceutical preparations • Connecticut
Contract Type FiledMarch 7th, 2017 Company Industry JurisdictionThis Change in Control and Severance Agreement (this “Agreement”) is entered into by and between [·] (the “Executive”) and Loxo Oncology, Inc., a Delaware corporation (the “Company”), on March 6, 2017 (the “Effective Date”).
March 6, 2017Loxo Oncology, Inc. • March 7th, 2017 • Pharmaceutical preparations • New York
Company FiledMarch 7th, 2017 Industry JurisdictionOn behalf of Loxo Oncology, Inc. (the “Company”), the Board of Directors of the Company (the “Board”) is very pleased to offer you this amended and restated employment agreement (the “Agreement”):